NEU 0.73% $19.06 neuren pharmaceuticals limited

Figure five they refer to below states its a non-risk adjusted...

  1. 1,543 Posts.
    lightbulb Created with Sketch. 289
    Figure five they refer to below states its a non-risk adjusted valuation.

    As a thought exercise, if NNZ-2591 is successful across all four current indications under development by NEU, we believe that asset's opportunity to be worth ~A$21.5 per share (see Figure 5).
 
watchlist Created with Sketch. Add NEU (ASX) to my watchlist
(20min delay)
Last
$19.06
Change
-0.140(0.73%)
Mkt cap ! $2.460B
Open High Low Value Volume
$18.76 $19.35 $18.71 $7.893M 414.4K

Buyers (Bids)

No. Vol. Price($)
1 842 $19.05
 

Sellers (Offers)

Price($) Vol. No.
$19.07 36 1
View Market Depth
Last trade - 16.10pm 01/05/2024 (20 minute delay) ?
Last
$19.11
  Change
-0.140 ( 0.78 %)
Open High Low Volume
$18.80 $19.34 $18.73 90497
Last updated 15.59pm 01/05/2024 ?
NEU (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.